About IPS Middle East
Integrated Pharma Solutions was founded in 2012 and is located in Beirut, Lebanon. Generic finished formulations are produced in the pharmaceutical sector, covering antibiotics, gastrointestinal treatments, proton pump inhibitors, neurology, dermatology, cardiovascular, and lifestyle products. Operations focus on manufacturing for distribution in the Middle East and North Africa region.
- Headquarter Beirut, Lebanon
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Maine Potato Growers, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Xantis Pharma
(Dec 01, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IPS Middle East
Detailed funding history for IPS Middle East
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IPS Middle East
IPS Middle East has secured backing from 1 investor. Prominent investors backing the company include Xantis Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Distributor of generic prescription and over-the-counter products
|
Locked | Locked | Locked |
Investor details for IPS Middle East
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IPS Middle East
Investment portfolio details for IPS Middle East
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IPS Middle East
Detailed financials for IPS Middle East
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ips Middle East Comparisons
Peer comparison for IPS Middle East
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IPS Middle East
Detailed competitors of IPS Middle East
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ips Middle East
Complete news archive for IPS Middle East
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IPS Middle East
IPS Middle East was founded in 2012.
IPS Middle East is headquartered in Beirut, Lebanon.
Integrated Pharma Solutions was founded in 2012 and is located in Beirut, Lebanon. Generic finished formulations are produced in the pharmaceutical sector, covering antibiotics, gastrointestinal treatments, proton pump inhibitors, neurology, dermatology, cardiovascular, and lifestyle products. Operations focus on manufacturing for distribution in the Middle East and North Africa region.
IPS Middle East has 1 investor. Key investors include Xantis Pharma.